Indefinite Delivery Contract 36C26126D0004

Award Date 10/1/25
Last Date to Order 9/30/30
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in-vitro diagnostics, reagents, and laboratory instruments. The contract, valued at $2,078,426.00, is for the preparation and staining of histology slides for the VA's medical facilities. Roche Diagnostics holds multiple Indefinite Delivery Vehicle (IDV) contracts and Blanket Purchase Agreements (BPAs) with various federal...
The Department of Veterans Affairs Veterans Health Administration, Network Contracting Office 6 has awarded a single award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, for the provision of histology consumables, test kits, reagents, and supplies. The $4.66 million contract, which runs from October 1, 2025 to September 30, 2026, will support six VA Medical Center laboratories and seven Health Care Centers...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 has awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract, with a total ceiling value of $133,203.95, covers the provision of Histology Special Stainer Testing services for the Buffalo VA Medical Center from October 1, 2025, through September 30, 2030. The initial task order,...
This indefinite delivery contract was awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. The contract is for histology staining services with a total ceiling value of $1,600,000 and a period of performance through September 30, 2025. This award is not set aside and provides the VA with a streamlined mechanism to...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded an Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for immunochemistry and immunohistochemistry laboratory testing services. The single-award IDC, valued at $2.3 million, was awarded on November 13, 2020 and has an ultimate completion date of November 12, 2025. Under this IDC, the VA has placed multiple firm fixed price delivery orders with Roche...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, an Indefinite Delivery Contract (IDC) to provide molecular pathology products and services. Under this IDC, the VA has issued multiple firm fixed-price delivery orders to Roche Diagnostics over a 5-year period, with a total ceiling value of $3,000,000. The delivery orders will supply clinical chemistry analyzers, reagents, test...
This is an Indefinite Delivery Contract (IDC) awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and medical laboratory equipment. The contract, with a ceiling value of $247,853.70, is for the provision of Roche HE600 and Benchmark reagents to support the VA's healthcare operations. The contract includes a $49,570.74 delivery order that adds new line items to the existing IDC. The...
This indefinite delivery contract was awarded by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 9 (VISN 9), to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The single-award IDC has a ceiling value of $815,294.66 and a period of performance from October 1, 2021 to September 30, 2026. The contracted products and services include...
The Department of Veterans Affairs, Veterans Health Administration (VA-VHA) has awarded an Indefinite Delivery Contract (IDC) worth up to $3,118,396.46 to Roche Diagnostics Corporation to provide immunohistochemistry cost per test services. This single-award IDC has a period of performance through September 30, 2027. Under this contract, Roche Diagnostics has been issued a series of firm-fixed price delivery orders to perform immunohistochemistry testing services in support of VA healthcare...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The $1.56 million IDC, with a period of performance through June 2030, is for the service, maintenance, and supply of Roche Ventana instruments used by the VA's Veterans Integrated Service Network 16. This procurement was not set aside for any specific business...
  • 36C26126D0004
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract, valued at up to $2,500,000, covers the delivery of Hematoxylin and Eosin Staining (H&E), Immunohistochemistry (IHC), In-Situ Hybridization (ISH), and Special Staining services on a cost per kit basis to the VA's Veterans Integrated Service Network 21, a civilian healthcare system.

The contract has a period of performance from October 1, 2025 through September 30, 2030, and does not have a set-aside designation, indicating Roche Diagnostics competed openly for the work. A related $424,086.16 delivery order under this contract was awarded for H&E IHC/ISH diagnostic services from October 1, 2025 through September 30, 2026. The original sources sought notice indicated the VA was conducting market research to identify potential suppliers of these laboratory staining services to support its healthcare operations and diagnostic needs across the VA system.

Generated 10/2/25, 11:07 AM